Alerts will be sent to your verified email
Verify EmailDHANROTO
|
Dhanalaxmi Roto Spin
|
Filtra Consultants
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.43 % | 14.05 % | -2.16 % |
|
5yr average Equity Multiplier
|
1.65 | 1.85 | 1.43 |
|
5yr Average Asset Turnover Ratio
|
2.43 | 2.36 | 1.33 |
|
5yr Avg Net Profit Margin
|
5.25 % | 3.2 % | 0.06 % |
|
Price to Book
|
1.09 | 2.77 | 34.55 |
|
P/E
|
6.21 | 23.14 | 46.57 |
|
5yr Avg Cash Conversion Cycle
|
8.07 Days | 36.46 Days | 362.19 Days |
|
Inventory Days
|
4.2 Days | 55.87 Days | 0.0 |
|
Days Receivable
|
51.03 Days | 34.62 Days | 362.19 Days |
|
Days Payable
|
42.28 Days | 66.81 Days | 18.78 Days |
|
5yr Average Interest Coverage Ratio
|
13.94 | 65.13 | -272.71 |
|
5yr Avg ROCE
|
29.7 % | 19.83 % | -0.79 % |
|
5yr Avg Operating Profit Margin
|
4.13 % | 4.39 % | 1.78 % |
|
5 yr average Debt to Equity
|
0.1 | 0.02 | 0.06 |
|
5yr CAGR Net Profit
|
16.09 % | 9.36 % | 24.57 % |
|
5yr Average Return on Assets
|
12.42 % | 7.6 % | -1.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.64 % | 72.45 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.73 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dhanalaxmi Roto Spin
|
Filtra Consultants
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|